p56^lck Activity and Expression in Peripheral Blood Lymphocytes from Patients with Systemic Lupus Erythematosus

References

• Via C. S., Handwerger B. S. B-cell and T-cell function in systemic lupus erythematosus. Curr. Opinion Rheumatol. 1993; 5: 570–574
   PubMedGoogle Scholar
• Dayal A. K., Kammer G. M. The T cell enigma in lupus. Arthritis Rheum. 1996; 39: 23–33
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A. N., Prud'Homme G. J., Dixon F. J. Autoimmune aspects of systemic lupus erythematosus. Concepts Immunopathol. 1985; 1: 190–218
   PubMedGoogle Scholar
• Tsokos G. C. Overview of cellular immune function in systemic lupus erythematosus. Systemic Lupus Erythematosus, R. G. Lahita. Churchill Livingstone, New York 1992; Vol. 2
   Google Scholar
• Gottlieb A. B., Lahita R. G., Chiorazzi N., Kunkel H. G. Immune function in systemic lupus erythematosus: impairment of in vitro T cell proliferation and in vivo antibody response to exogenous antigen. J. Clin. Invest. 1979; 63: 885–892
   PubMed Web of Science ®Google Scholar
• Via C. S., Tsokos G. C., Bermas B., Clerici M., Shearer G. M. T-cell-antigen-presenting cell interaction in human systemic lupus erythematosus: evidence for heterogeneous expression of multiple defects. J. Immunol. 1993; 151: 3914–3922
   PubMed Web of Science ®Google Scholar
• Horwitz D. A., Garett M. A. Lymphocytes reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin. Exp. Immunol. 1977; 27: 92–99
   PubMed Web of Science ®Google Scholar
• Stohl W. Impaired generation of polyclonal T cell-mediated cytosolic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus. Clin. Immunol. Immunpathol. 1992; 63: 163–172
   PubMedGoogle Scholar
• Fox D. A., Millard J. A., Treisman J., Zeldes W., Bergman A., Depper J., Dunne R., McCune W. J. Defective CD2 pathway T cell activation in systemic lupus erythematosus. Arthritis. Rheum. 1991; 34: 561
   PubMed Web of Science ®Google Scholar
• Bakke A. C., Kirkland P. A., Kitridou R. C., Quismorio F. P., Rea T., Ehresmann G. R., Horwitz D. A. T lymphocytes subsets in systemic lupus erythematosus. Arthritis Rheum. 1983; 26: 745–750
   PubMed Web of Science ®Google Scholar
• Kammer G. M., Khan I. U., Malemud C. J. Deficient Type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J. Clin. Invest. 1994; 94: 422–430
   PubMed Web of Science ®Google Scholar
• Tada Y., Nagasawa K., Yamauchi Y., Tsukamoto H., Niho Y. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1991; 60: 230–231
   Google Scholar
• Vassilopoulos D., Kovacs B., Tsokos G. C. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 1995; 155: 2269–2281
   PubMed Web of Science ®Google Scholar
• Matache C., Stefanescu M., Onu A., Szegli G., Barel M., Tanaseanu S., Matei I., Bouillie S., Frade R. Tyrosine phosphorylation in peripheral lymphocytes from patients with systemic lupus erythematosus. Autoimmunity 1996; 24: 217–228
   PubMed Web of Science ®Google Scholar
• Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H. and Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum. 1992; 35: 630–640
   PubMed Web of Science ®Google Scholar
• Stefanescu M., Cremer L., Cristescu C., Matache C., Szegli G. Anti-phosphotyrosine antibodies: obtaining and purification. Roum. Arch. Microbiol. Immunol. 1991; 50: 187–192
   PubMedGoogle Scholar
• Mustelin T. Src-like kinases: A family of ten. Src Family Tyrosine Kinases in Leukocytes. R.G. Landes Company, Austin 1994; 8–33, Molecular Biology Intelligence Unit
   Google Scholar
• Rudd C. E., Janssen O., Prasad K. V.S., Raab M., da Silva A., Telfer J. C., Yamamoto M. sre-related protein tyrosine kinases and their surface receptors. Biochim. Biophys. Acta 1993; 1155: 239–266
   PubMed Web of Science ®Google Scholar
• Olszowy M. W., Leuchtmann P. L., Veillette A., Shaw A. S. Comparison of p56 lck and p59 fyn protein expression in tymocytes subsets, peripheral T cells, NK cells, and lymphoid cell lines. J. Immunol. 1995; 155: 4236–4240
   PubMed Web of Science ®Google Scholar
• Danielian S., Alcover A., Polissard L., Stefanescu M., Acuto O., Fischer S., Fagard R. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-indepenent and CD45-dependent activation of p56lck. Eur. J. Immunol. 1992; 22: 2915–2921
   PubMed Web of Science ®Google Scholar
• Couture C., Songyang Z., Jascure T., Williams S., Tailor P., Cantley L. C., Mustelin T. Regulation of the Lck SH2 domain by tyrosine phosphotylation. J. Biol. Chem. 1996; 271: 24880–24884
   PubMed Web of Science ®Google Scholar
• Lee-Fruman K. K., Collins T. L., Burakoff S. J. Role of the Lck Src homology 2 and 3 domains in protein tyrosine phosphorylation. J. Biol. Chem. 1996; 271: 25003–25010
   PubMed Web of Science ®Google Scholar
• Marth J. D., Lewis D. B., Wilson C. B., Gearn M. E., Krebs E. G., Perlmutter R. M. Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases. EMBO J. 1987; 6: 2727–2734
   PubMed Web of Science ®Google Scholar
• Vanhee-Brossollet C., Vaquero C. Regulation of p56 (lck) messengers turnover upon T cell activation: involvement of the 3' untranslated region in stability as determined in cell-free extracts. Biochem. Biophys. Res. Com. 1997; 233: 419–424
   PubMed Web of Science ®Google Scholar
• Emlen W., Niebur J. A., Kadera R. Accelerated in vitro appoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 1994; 152: 3685–3892
   PubMed Web of Science ®Google Scholar
• Lorenz H. M., Grunke M., Hieronymus T., Herrmann M., Kuhnel A., Manger B., Kalden J. R. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis & Rheumatism 1997; 40: 306–317
   PubMed Web of Science ®Google Scholar
• Gonzalez-Garcia A., R-Borlado L., Leonardo E., Merida I., Martincz-A C., Carrera A. C. Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J. Immunol. 1997; 158: 4104–4112
   PubMed Web of Science ®Google Scholar
• Di Somma M. M., Nuti S., Telford J. L., Baldari C. T. p561ck plays a key role in transducing apoptotic signals in T cells. FEBS Lett. 1995; 363: 101–104
   PubMed Web of Science ®Google Scholar
• Garcia-Welsh A., Laskin D. L., Shuler R. L., Laskin J. D. Cellular depletion of p56lck during thymocyte apoptosis. J Leukocyte Biology 1994; 56: 528–532
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Sohn S. J., Levin S. D., Tada T., Perlmutter R. M., Nakayama T. Requirement for p56lck tyrosine kinase activation in T cell receptor-mediated thymic selection. J. Exp. Med. 1996; 184: 931–943
   PubMed Web of Science ®Google Scholar
• Gajewski T. F., Qian D., Fields P., Fitch F. W. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. USA 1994; 91: 38–42
   PubMed Web of Science ®Google Scholar
• Ah Cho E., Rley M. P., Sillman A. L., Quill H. Altered protein tyrosine phosphorylation in anergic Th1 cells. J. Immunol. 1993; 151: 20–28
   PubMed Web of Science ®Google Scholar
• Mitchell T. M. Okadaic acid-like toxin in systemic lupus erythematosus patients: hypothesis for toxin-induced pathology, immune dysregulation, and trans-activation of herpesviruses. Medical Hypotheses 1996; 47: 217–225
   PubMed Web of Science ®Google Scholar
• Churcher Y., Moss S. F. Inhibition of interleukin-2-mediated DNA synthesis in activated human T-lymphoblasts by okadaic acid is accompanied by hyper-phosphorylation of lck. Biochem. J. 1995; 308: 777–783
   PubMed Web of Science ®Google Scholar